PHARMAXIS' FIRST COMMERCIAL SALE OF ARIDOL TO U.S. MARKET

Pharmaxis today announced that a U.S. pharmaceutical company has placed an order to purchase Aridol test kits for a series of asthma trials evaluating its new asthma therapeutic. The phase II trials will be conducted in North America and are expected to commence later this year. Yahoo News (http://biz.yahoo.com/prnews/060630/hkf002.html?.v=33)